Therapeutics
HF0220
Quick Links
Overview
Name: HF0220
Therapy Type: Small Molecule (timeline)
Target Type: Inflammation (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Company: Newron
Background
Last Updated: 10 Aug 2013
References
No Available References
Further Reading
No Available Further Reading
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.